Skip to main content

Wells Fargo Keeps Their Hold Rating on Zimmer Biomet Holdings (ZBH)

Tipranks - Tipranks - Thu Feb 12, 6:42AM CST

In a report released today, Larry Biegelsen from Wells Fargo maintained a Hold rating on Zimmer Biomet Holdings, with a price target of $98.00.

Valentine's Day Sale - 70% Off

Biegelsen covers the Healthcare sector, focusing on stocks such as Inspire Medical Systems, Edwards Lifesciences, and Johnson & Johnson. According to TipRanks, Biegelsen has an average return of 2.0% and a 49.90% success rate on recommended stocks.

In addition to Wells Fargo, Zimmer Biomet Holdings also received a Hold from Canaccord Genuity’s Caitlin Cronin in a report issued today. However, on the same day, TipRanks – PerPlexity upgraded Zimmer Biomet Holdings (NYSE: ZBH) to a Buy.

See Insiders’ Hot Stocks on TipRanks >>

Based on Zimmer Biomet Holdings’ latest earnings release for the quarter ending September 30, the company reported a quarterly revenue of $2 billion and a net profit of $230.9 million. In comparison, last year the company earned a revenue of $1.82 billion and had a net profit of $249.1 million

Read More on ZBH:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).